Alec Machiels, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 2,500 shares at $59.31 ($148K) on 2022-10-14, disclosed to the SEC on 2022-10-17.
Open-market sale of $148k APLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.31 | 1,250 | $74K | 50.0% |
| 2 | $59.31 | 1,250 | $74K | 50.0% |
| Total | $59.31 avg | 2,500 | $148K | 100% |
| Filing → |
| APLS | SELL | 2023-09-19 | $56K | — | Filing → |
| APLS | SELL | 2023-09-18 | $113K | — | Filing → |
| APLS | SELL | 2023-07-18 | $162K | — | Filing → |